Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Granulocyte-macrophage colony-stimulating factor
(
GM-CSF
), one of major hematopoietic growth factors, activates mature leukocytes.
GM-CSF
is produced by endothelial cells stimulated with lipopolysaccharide (LPS), and the LPS-induced
GM-CSF
production may play an important role in the activation of neutrophils on the endothelial surface. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ2) is a ligand for peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and modulates inflammatory reactions by regulating the expression of various genes. We studied the effect of 15d-
PGJ2
on the LPS-induced
GM-CSF
expression in endothelial cells. Human umbilical vein endothelial cells (HUVEC) were cultured and the expressions of
GM-CSF
mRNA and protein were analyzed by reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. 15d-
PGJ2
inhibited the LPS-induced
GM-CSF
expression in a concentration-dependent manner; but ciglitazone, another agonist for PPAR-gamma, had no effect. This suggests that 15d-
PGJ2
inhibits
GM-CSF
expression through a mechanism unrelated to PPAR-gamma. 15d-
PGJ2
induced, by itself, the expression of interleukin-8, a potent proinflammatory chemokine, in HUVEC. 15d-
PGJ2
may regulate inflammatory reactions by controlling the balance of various cytokines.
...
PMID:15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide. 1451 69
15-Deoxy-delta(12,14)-prostaglandin J2 (15d-
PGJ2
) is an agonist for peroxisome proliferator-activated receptor-gamma (PPAR-gamma), which plays an important role in various biological processes including inflammatory responses. We have addressed the effect of 15d-
PGJ2
on the expression of
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) in a cell line derived from human bronchial epithelial cells (BEAS-2B). Besides being a hematopoietic growth factor,
GM-CSF
activates mature leukocytes and is involved in regulation of inflammatory responses. Cultures of BEAS-2B were stimulated with interleukin-1beta (IL-1beta), and the expressions of
GM-CSF
mRNA and protein were analyzed by reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. IL-1beta stimulated the expression of
GM-CSF
in BEAS-2B cells in concentration- and time-dependent manners. When the cells were pretreated with 15d-
PGJ2
for 1 hour, the IL-1beta-induced
GM-CSF
expression was inhibited in a concentration-dependent manner (2-50 microM). Ciglitazone, another agonist of PPAR-gamma, did not affect the IL-1beta-induced
GM-CSF
expression in BEAS-2B cells. A PPAR-gamma antagonist, bisphenol A diglycide ether (BADGE), did not reverse the inhibitory effects of 15d-
PGJ2
on
GM-CSF
expression. 15d-
PGJ2
regulates
GM-CSF
expression in the bronchial epithelium, which may be mediated through a mechanism unrelated to PPAR-gamma.
...
PMID:15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells. 1499